TABLE 1.
MFIs of cell-surface molecules
| Surface molecule | M-CSF–derived MDMs | GM-CSF–derived MDMs |
|---|---|---|
| CD4 | 7.20 ± 0.67 | 6.15 ± 0.26 |
| CCR5 | 8.51 ± 0.59 | 10.11 ± 0.65 |
| DC-SIGN | 7.12 ± 0.49 | 3.05 ± 0.69 |
| CD16 | 13.90 ± 1.38 | 3.61 ± 0.51 |
| CD32 | 258.00 ± 65.15 | 178.10 ± 73.48 |
| CD64 | 15.81 ± 0.72 | 6.45 ± 0.72 |
| CD40 | 12.72 ± 1.39 | 18.11 + 1.70 |
| CD80 | 10.15 ± 0.74 | 11.80 ± 0.62 |
| CD86 | 98.51 ± 1.16 | 112.93 ± 5.08 |
| MHC I | 301.10 ± 13.11 | 265.51 ± 11.12 |
| MHC II | 490.82 ± 16.93 | 465.54 ± 12.35 |
| CD1a | 10.25 ± 1.91 | 8.83 ± 0.82 |
| CD11b | 44.95 ± 5.42 | 83.53 ± 4.47 |
| CD14 | 79.15 ± 12.11 | 16.48 ± 2.13 |
| Siglec-1 | 88.83 ± 9.57 | 16.28 ± 4.64 |
| Siglec-3 | 86.00 ± 6.14 | 23.10 ± 4.24 |
| Siglec-5 | 15.83 ± 6.51 | 8.80 ± 1.31 |
| Siglec-9 | 51.83 ± 7.20 | 47.05 ± 4.68 |
The MFI of cell-surface markers was determined by flow cytometry. Values are from triplicate samples (means ± sd) from M-CSF– and GM-CSF–derived MDMs from 4 different donors.